GSK’s R&D chief to leave for UK gov role? by Selina McKee | Nov 6, 2017 | News | 0 GlaxoSmithKline’s head of R&D Patrick Vallance is reportedly leaving the firm to take on the role of chief scientific advisor at the government. Read More
GSK names new chief executive by Selina McKee | Sep 20, 2016 | News | 0 GlaxoSmithKline has announced that Emma Walmsley will take over from current chief executive Andrew Witty following his retirement at the end of March next year. Read More